PathAI
PathAI runs the AISight AI pathology platform and quantifies biomarkers for pharma trials.
AISight image management, AIM-PD-L1 and AIM-HER2 quantification, TumorDetect; large pharma partnerships.
Pages like this
not linked directly; found by shared links- CompanyPaige AI
Shares A standard evaluation pathway for AI-assisted pathology, from reader study to deployment, AI second reads to stop borderline lesions being upgraded to cancer, Version control and locked reference sets for AI algorithms used as companion diagnostics, A pre-competitive consortium to train a shared multimodal cancer foundation model.
- IdeaAI quantification of HER2-low and HER2-ultralow
Shares A standard evaluation pathway for AI-assisted pathology, from reader study to deployment, Version control and locked reference sets for AI algorithms used as companion diagnostics, AI-first reading for high-volume common cancer diagnoses, pathologist for the exceptions, Digital pathology & AI.
- IdeaPublic gold-standard datasets for validating every cancer biomarker test
Shares Version control and locked reference sets for AI algorithms used as companion diagnostics, One digital PD-L1 scale that maps across all the competing assays, Digital pathology & AI, AI that is built but not validated or deployed.
- IdeaPathologist assistants plus AI triage to multiply pathologist capacity
Shares AI-first reading for high-volume common cancer diagnoses, pathologist for the exceptions, Digital pathology & AI, Not enough oncologists, nurses, pathologists, physicists, AI that is built but not validated or deployed.
- IdeaFederated training of pathology and radiology models across hospitals
Shares A pre-competitive consortium to train a shared multimodal cancer foundation model, Digital pathology & AI, AI that is built but not validated or deployed.
- CompanyOwkin
Shares A pre-competitive consortium to train a shared multimodal cancer foundation model, AI-first reading for high-volume common cancer diagnoses, pathologist for the exceptions, Digital pathology & AI, AI that is built but not validated or deployed.
- CompanyLunit
Shares AI-first reading for high-volume common cancer diagnoses, pathologist for the exceptions, Digital pathology & AI, Not enough oncologists, nurses, pathologists, physicists, AI that is built but not validated or deployed.
- TechnologyPathology & radiology foundation models
Shares PLUTO (PathAI), AI second reads to stop borderline lesions being upgraded to cancer, Version control and locked reference sets for AI algorithms used as companion diagnostics, A pre-competitive consortium to train a shared multimodal cancer foundation model.